2-189057366-G-C

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PP2PP3BP4_StrongBP6BS1BS2

The NM_000393.5(COL5A2):ā€‹c.2291C>Gā€‹(p.Pro764Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000402 in 1,608,322 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00070 ( 0 hom., cov: 31)
Exomes š‘“: 0.00037 ( 1 hom. )

Consequence

COL5A2
NM_000393.5 missense

Scores

12
4
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:9

Conservation

PhyloP100: 10.0
Variant links:
Genes affected
COL5A2 (HGNC:2210): (collagen type V alpha 2 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), COL5A2. . Gene score misZ 2.4395 (greater than the threshold 3.09). Trascript score misZ 3.3523 (greater than threshold 3.09). GenCC has associacion of gene with Ehlers-Danlos syndrome, classic type, 2, Ehlers-Danlos syndrome, classic type.
PP3
Multiple lines of computational evidence support a deleterious effect 9: AlphaMissense, BayesDel_addAF, BayesDel_noAF, Cadd, Eigen, phyloP100way_vertebrate, PrimateAI, PROVEAN, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.02394256).
BP6
Variant 2-189057366-G-C is Benign according to our data. Variant chr2-189057366-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 213106.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=5, Uncertain_significance=2, Benign=3}. Variant chr2-189057366-G-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000697 (103/147864) while in subpopulation AMR AF= 0.00292 (43/14726). AF 95% confidence interval is 0.00223. There are 0 homozygotes in gnomad4. There are 55 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 103 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL5A2NM_000393.5 linkuse as main transcriptc.2291C>G p.Pro764Arg missense_variant 34/54 ENST00000374866.9 NP_000384.2 P05997
COL5A2XM_011510573.4 linkuse as main transcriptc.2153C>G p.Pro718Arg missense_variant 37/57 XP_011508875.1
COL5A2XM_047443251.1 linkuse as main transcriptc.2153C>G p.Pro718Arg missense_variant 39/59 XP_047299207.1
COL5A2XM_047443252.1 linkuse as main transcriptc.2153C>G p.Pro718Arg missense_variant 38/58 XP_047299208.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL5A2ENST00000374866.9 linkuse as main transcriptc.2291C>G p.Pro764Arg missense_variant 34/541 NM_000393.5 ENSP00000364000.3 P05997
COL5A2ENST00000618828.1 linkuse as main transcriptc.1130C>G p.Pro377Arg missense_variant 27/475 ENSP00000482184.1 A0A087WYX9
COL5A2ENST00000470524.2 linkuse as main transcriptn.397C>G non_coding_transcript_exon_variant 7/85

Frequencies

GnomAD3 genomes
AF:
0.000697
AC:
103
AN:
147824
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000124
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00292
Gnomad ASJ
AF:
0.0119
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000164
Gnomad OTH
AF:
0.00147
GnomAD3 exomes
AF:
0.000776
AC:
195
AN:
251302
Hom.:
0
AF XY:
0.000817
AC XY:
111
AN XY:
135804
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00101
Gnomad ASJ exome
AF:
0.0128
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000202
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000372
AC:
543
AN:
1460458
Hom.:
1
Cov.:
33
AF XY:
0.000366
AC XY:
266
AN XY:
726532
show subpopulations
Gnomad4 AFR exome
AF:
0.0000897
Gnomad4 AMR exome
AF:
0.000962
Gnomad4 ASJ exome
AF:
0.0120
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000963
Gnomad4 OTH exome
AF:
0.00129
GnomAD4 genome
AF:
0.000697
AC:
103
AN:
147864
Hom.:
0
Cov.:
31
AF XY:
0.000767
AC XY:
55
AN XY:
71672
show subpopulations
Gnomad4 AFR
AF:
0.000124
Gnomad4 AMR
AF:
0.00292
Gnomad4 ASJ
AF:
0.0119
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000164
Gnomad4 OTH
AF:
0.00146
Alfa
AF:
0.00101
Hom.:
0
Bravo
AF:
0.000778
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.000552
AC:
67
EpiCase
AF:
0.000382
EpiControl
AF:
0.000296

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Ehlers-Danlos syndrome, classic type, 2 Benign:2
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 26, 2023- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024COL5A2: PP3, BS1, BS2 -
Likely benign, criteria provided, single submitterclinical testingGeneDxSep 14, 2020- -
Ehlers-Danlos syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenSep 20, 2021- -
Connective tissue disorder Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCenter for Human Genetics, Inc, Center for Human Genetics, IncJun 01, 2018- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 06, 2024- -
COL5A2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesDec 16, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Familial thoracic aortic aneurysm and aortic dissection Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJan 24, 2017This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Ehlers-Danlos syndrome type 7A Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Ehlers-Danlos syndrome, classic type, 1 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.69
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Pathogenic
0.51
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.83
D;T;D
Eigen
Pathogenic
0.79
Eigen_PC
Pathogenic
0.82
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.75
.;T;D
M_CAP
Uncertain
0.19
D
MetaRNN
Benign
0.024
T;T;T
MetaSVM
Pathogenic
0.94
D
MutationAssessor
Uncertain
2.2
M;.;M
PrimateAI
Pathogenic
0.83
D
PROVEAN
Pathogenic
-7.9
D;.;.
REVEL
Pathogenic
0.70
Sift
Uncertain
0.011
D;.;.
Sift4G
Pathogenic
0.0010
D;D;.
Polyphen
1.0
D;.;D
Vest4
0.86
MVP
0.93
MPC
0.27
ClinPred
0.15
T
GERP RS
5.9
Varity_R
0.36
gMVP
0.63

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150260969; hg19: chr2-189922092; COSMIC: COSV66410496; API